• Hikma attended the 5th Annual International Oncology Forum IOF 2026 in the UAE as a platinum sponsor alongside Guardant Health.
• Hikma highlighted FDA clearance of Guardant360 Liquid CDx, positioning it to expand precision oncology diagnostics across MENA under its 2024 exclusive deal.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hikma Pharmaceuticals plc published the original content used to generate this news brief on June 22, 2026, and is solely responsible for the information contained therein.